AMPLITUDE ANNOUNCES STRATEGIC AGREEMENT TO ACCELERATE INNOVATION IN MULTIPHOTON IMAGING SOLUTIONS
Amplitude unveils FOCUS 920 femtosecond laser, a new reference for bioimaging and neuroscience.
Bordeaux, France – January 20, 2026 – Guided by a long-standing commitment to supporting advances in life-science research, Amplitude, a global leader in ultrafast laser technologies, and indie, one of the fastest-growing innovators in automotive semiconductors and advanced photonics technologies, today announced that they are entering into a strategic partnership.
As a first success stemming from this agreement, Amplitude has recently launched the FOCUS 920, a compact femtosecond Fiber laser, powered by indie’s ultrafast laser technology, designed for demanding bioimaging and neuroscience applications. Building on this foundation, the collaboration aims to expand Amplitude’s life sciences product portfolio and accelerate the development of next-generation multiphoton imaging solutions.
“Entering into this agreement with indie represents an important strategic milestone for Amplitude,” said Damien Buet, President & CEO of Amplitude Laser Group. “It strengthens our offering in life sciences today with the FOCUS 920, and reflects our shared ambition to deliver high-performance, reliable, and accessible photonics solutions that support progress in bioimaging and medical research.”
“This partnership marks an important step in indie’s evolution as a key supplier of lasers across multiple end markets, including bioimaging, automotive LiDAR, and Quantum,” said Mathieu Drolet, Executive Vice President of indie’s Photonics Business Unit. “By powering Amplitude’s FOCUS 920, we’re integrating indie’s advanced photonics expertise into nonlinear bioimaging solutions and accelerating overall market adoption through this partnership.
Launched in the year of Amplitude’s 25th anniversary, the FOCUS 920 further reinforces the company’s foothold in bioimaging and neuroscience applications. Compact, air-cooled and powerful, the system is engineered for exceptional reliability, ensuring stable operation and consistent performance over time—key requirements in research and clinical environments.
The FOCUS 920 is built around Amplitude’s HB-LH (High Brightness – Low Heat) concept, developed in close collaboration with indie to maximize image quality while preserving living samples. Its combination of short pulse duration and high pulse energy combined with low average power enables bright, high-contrast imaging while limiting sample heating and photodamage. This balance is key for long-term imaging and sensitive neuroscience and bioimaging experiments.
Within the life sciences sector, the FOCUS 920 addresses a broad range of bioimaging applications and complements Amplitude’s existing product portfolio for two-photon photostimulation in neuroscience. It is designed to support researchers working on advanced imaging and functional interrogation of neural circuits, where reliability, stability, and controlled femtosecond excitation parameters are essential.
Amplitude has a strong track record of bringing disruptive laser technologies from research to large-scale deployment. In ophthalmology, the company pioneered the integration of ultrafast femtosecond lasers into laser eye surgery systems in 2007—an innovation that scaled to thousands of installations worldwide and continues to benefit millions of patients today. The Group has also played a key role in advancing display manufacturing, enabling major technology companies to redefine production standards through advanced laser systems.
Headquartered in Pessac, near Bordeaux, in the Nouvelle-Aquitaine region of France, Amplitude leverages a strong local ecosystem for deep-tech innovation and industrial excellence, while serving a global customer base across Europe, Asia, and the United States.
With this strategic agreement and the launch of the FOCUS 920, Amplitude takes a significant step in expanding its product portfolio dedicated to multiphoton imaging, reinforcing its long-term commitment and vision to advancing life sciences through ultrafast laser innovation.
About indie
indie (Nasdaq: INDI) is empowering the automotive revolution with next-generation semiconductors, photonics, and perception software platforms.
indie’s photonics BU leads the evolution of photonics by delivering innovative light-based solutions for diverse industries. Our expertise includes fiber-optic components, low-noise lasers, ultrashort pulse fiber lasers, custom integrated photonics packaging, and advanced light sources such as our Superluminescent Light Emitting Diodes (SLEDs) and visible DFBs.
With a proven track record and over one million photonic solutions deployed worldwide, we offer end-to-end solutions tailored to applications in sensing, quantum, medical, drones, aerospace, automotive, and beyond.
To learn more, please visit us at www.indie.inc